Mediwhale, an eight-year-old Seoul startup that uses AI to analyze retinal images and predict the risk of cardiovascular, kidney, and eye diseases, raised a $12 million Series A2 round led by Korea Development Bank, with Woori Venture Partners, IMM Investment, and Mirae Asset Securities also anteing up. More here.

Curated from Strictly VC Newsletter